SPAK inhibitor ZT‐1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia is a research paper published in CNS Neuroscience & Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: BX003923
U.S. Department of Veterans Affairs
Grant: I01BX002891‐01A1
National Institute of Neurological Disorders and Stroke
Grant: R01NS119166
National Institute of Neurological Disorders and Stroke
Grant: RF1NS117509
National Institutes of Health
Grant: 5G12M007590
National Institutes of Health
Grant: 5G12MD007590-30
CANCER RESEARCH INFRASTRUCTURE DEVELOPMENT
National Institutes of Health
Grant: 1RF1NS117509-01
White Matter Restoration in Vascular Cognitive Impairment and dementia
National Institutes of Health
Grant: 7R01NS119166-02
Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury
National Institutes of Health
Grant: 2I01BX002891-05
SPAK inhibitor ZT-1a for ischemic stroke therapy
FWCI
2.19
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals